BioCentury
ARTICLE | Company News

Isis, Hybridon in antisense deal

May 25, 2001 7:00 AM UTC

ISIP obtained an exclusive license to HYBN's antisense chemistry and delivery technology, which includes an exclusive right to sub-license the HYBN technology to third parties. Additionally, HYBN rece...